An AllTrials project

NCT03859700: An ongoing trial by DBV Technologies

This trial is ongoing. It must report results 10 months, 4 weeks from now.

Full data

Full entry on ClinicalTrials.gov NCT03859700
Title EPITOPE Open-label Extension Study to Evaluate the Long-term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Dec. 6, 2018
Completion date May 13, 2025
Required reporting date May 13, 2026, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov June 18, 2025
Days late None